SwitzerlandHealthcare and life sciences2024 – ongoingRoche
Genetic-algorithm manufacturing scheduling
Roche reported 5% to 10% capacity gains on constrained assets from AI scheduling
Problem
Manufacturing schedules faced unpredictable disruptions.
Approach
Roche developed genetic-algorithm scheduling. It deployed the system globally.
Results
5% to 10%constrained-asset capacity gains reported by Roche
Takeaway
The scheduler combined production sequencing with maintenance planning and adjustments for unplanned events.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- Production and quality
- Innovation type
- Process innovation
- AI technology
- Optimization
- Adoption
- Built in-house
- Evidence
- Company's own claim
Sources
Source summaries
[1]BioProcess Online11 Oct 2024
Roche employees described genetic-algorithm scheduling across its global network. They reported capacity gains of 5% to 10% on constrained assets.
Full details are in the original sources.
Added 1 Nov 2026 · Updated 1 Nov 2026
